Detalles de la búsqueda
1.
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis.
Br J Dermatol;
187(4): 531-538, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442530
2.
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.
J Am Acad Dermatol;
86(2): 359-364, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34474079
3.
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5).
J Am Acad Dermatol;
85(1): 62-70, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33600915
4.
Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.
Health Qual Life Outcomes;
19(1): 247, 2021 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688290
5.
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
J Am Acad Dermatol;
83(3): 839-846, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32344071
6.
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.
J Am Acad Dermatol;
80(4): 913-921.e9, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410014
7.
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.
Nephrol Dial Transplant;
33(11): 1950-1959, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29481660
8.
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16.
Dermatol Ther (Heidelb);
12(1): 137-148, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34846636
9.
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials.
Am J Clin Dermatol;
22(3): 395-405, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826132
10.
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.
JAMA Dermatol;
157(6): 691-699, 2021 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33978711
11.
"'You lose your hair, what's the big deal?' I was so embarrassed, I was so self-conscious, I was so depressed:" a qualitative interview study to understand the psychosocial burden of alopecia areata.
J Patient Rep Outcomes;
4(1): 76, 2020 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914253
12.
Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.
Am J Clin Dermatol;
21(5): 725-732, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32803546
13.
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
JAMA Dermatol;
156(12): 1333-1343, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33001140
14.
A role for the p53 pathway in the pathology of meningiomas with NF2 loss.
J Neurooncol;
91(3): 265-70, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18974932
15.
Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings.
Hum Mutat;
28(1): 1-12, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16983642
16.
A phase 1 study of the Janus kinase 2 (JAK2)V617F inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential thrombocythemia.
Leuk Res;
61: 89-95, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28934680
17.
Antimicrobial susceptibility profile of enterobacteria isolated from wild grey-breasted parakeets (Pyrrhura griseipectus)
Pesqui. vet. bras;
412021.
Artículo
en Inglés
| LILACS-Express
| ID: biblio-1487679
18.
Antimicrobial susceptibility profile of enterobacteria isolated from wild grey-breasted parakeets (Pyrrhura griseipectus) / Perfil de susceptibilidade antimicrobiana de enterobactérias isoladas de periquitos-de-cara-suja (Pyrrhura griseipectus)
Pesqui. vet. bras;
41: e06696, 2021. tab
Artículo
en Inglés
| LILACS, VETINDEX | ID: biblio-1340354
19.
Current status and recommendations for biomarkers and biobanking in neurofibromatosis.
Neurology;
87(7 Suppl 1): S40-8, 2016 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27527649
20.
Turner syndrome and meningioma: support for a possible increased risk of neoplasia in Turner syndrome.
Eur J Med Genet;
57(6): 269-74, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24675142